Vericel Corp. (VCEL)
33.79
-1.34
(-3.81%)
USD |
NASDAQ |
May 08, 12:57
Vericel Research and Development Expense (Annual) : 27.56M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Marker Therapeutics, Inc. | 11.80M |
| Arbutus Biopharma Corp. | 25.24M |
| Tenaya Therapeutics, Inc. | 68.61M |
| Moderna, Inc. | 2.917B |
| Anavex Life Sciences Corp. | 37.59M |